Matthew R. Ruth, Chief Commercial Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 2,000 shares at $17.34 ($35K) on 2021-08-31, disclosed to the SEC on 2021-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.